Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Prostatic Neoplasms × vandetanib × Clear all

Phase

Status

Completed 2 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Thyroid Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Carcinoma, Renal Cell 2 Carcinoma, Medullary 2 Thyroid cancer, medullary 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Recurrence 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Mesothelioma 1 Kidney Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Breast Neoplasms 1 Adenocarcinoma, Follicular 1 Adenocarcinoma Of Esophagus 1

Interventions

Docetaxel 48 Prednisone 27 Leuprolide 21 enzalutamide 19 bicalutamide 15 Magnetic Resonance Spectroscopy 14 Goserelin 12 Abiraterone Acetate 12 Radiotherapy 11 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 10 abiraterone 9 cabazitaxel 8 Radiotherapy, Intensity-Modulated 8 olaparib 7 gallium 68 PSMA-11 7 Metformin 7 Ketoconazole 7 Gonadotropin-Releasing Hormone 7 Doxorubicin 7 Cyclophosphamide 7 Androgen Antagonists 7 luprolide acetate gel depot 6 Estramustine 6 pembrolizumab 5 cabozantinib 5 apalutamide 5 Radiosurgery 5 Mitoxantrone 5 Dexamethasone 5 Carboplatin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00686036 2016-12-21

ZENITH

Sanofi

Phase 2 Terminated

17 enrolled 4 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡